Jianmin Group announced that terbutaline sulfate solution for nebulized inhalation has been approved for marketing. This drug is used to relieve bronchospasm associated with bronchial asthma, chronic bronchitis, emphysema, and other lung diseases. It is suitable for adults and children.
健民集团：硫酸特布他林雾化吸入用溶液获批上市
Jianmin Group: Terbutaline sulfate nebulized inhalation solution approved for listing
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.